Landos Biopharma Financials
LABPDelisted Stock | USD 4.02 0.15 3.60% |
Landos |
Understanding current and past Landos Biopharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Landos Biopharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Landos Biopharma's assets may result in an increase in income on the income statement.
Landos Biopharma Stock Summary
Landos Biopharma competes with Cardio Diagnostics, Transcode Therapeutics, and Xenetic Biosciences. Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia. Landos Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US5150691021 |
Business Address | 1800 Kraft Drive, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | landosbiopharma.com |
Phone | 540 218 1767 |
Currency | USD - US Dollar |
Landos Biopharma Key Financial Ratios
Return On Equity | -0.71 | |||
Return On Asset | -0.39 | |||
Target Price | 12.71 | |||
Number Of Employees | 19 | |||
Beta | 0.14 |
Landos Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Landos Biopharma's current stock value. Our valuation model uses many indicators to compare Landos Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Landos Biopharma competition to find correlations between indicators driving Landos Biopharma's intrinsic value. More Info.Landos Biopharma is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Landos Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Landos Biopharma Market Pulse
Quote | 4.02 |
Change(%) | 3.60 |
Change | 0.15 |
Open | 4.17 |
Low | 3.94 |
High | 4.28 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Landos Biopharma is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Landos has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Landos Biopharma's financials are consistent with your investment objective using the following steps:- Review Landos Biopharma's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Landos Biopharma's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Landos Biopharma's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Landos Biopharma's stock is overvalued or undervalued.
Landos Biopharma November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Landos Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Landos Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Landos Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Landos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Landos Biopharma's daily price indicators and compare them against related drivers.
Downside Deviation | 4.51 | |||
Information Ratio | 0.098 | |||
Maximum Drawdown | 19.47 | |||
Value At Risk | (7.05) | |||
Potential Upside | 8.58 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Transaction History View history of all your transactions and understand their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |